6-135404993-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001134831.2(AHI1):​c.2962-16A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00975 in 1,593,840 control chromosomes in the GnomAD database, including 98 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0070 ( 5 hom., cov: 32)
Exomes 𝑓: 0.010 ( 93 hom. )

Consequence

AHI1
NM_001134831.2 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.435

Publications

1 publications found
Variant links:
Genes affected
AHI1 (HGNC:21575): (Abelson helper integration site 1) This gene is apparently required for both cerebellar and cortical development in humans. This gene mutations cause specific forms of Joubert syndrome-related disorders. Joubert syndrome (JS) is a recessively inherited developmental brain disorder with several identified causative chromosomal loci. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2008]
AHI1 Gene-Disease associations (from GenCC):
  • Joubert syndrome 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Laboratory for Molecular Medicine, Ambry Genetics
  • Joubert syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome with ocular defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AR, AD Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 6-135404993-T-C is Benign according to our data. Variant chr6-135404993-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260852.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.007 (1066/152292) while in subpopulation NFE AF = 0.0106 (718/68002). AF 95% confidence interval is 0.00992. There are 5 homozygotes in GnomAd4. There are 536 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AHI1NM_001134831.2 linkc.2962-16A>G intron_variant Intron 21 of 28 ENST00000265602.11 NP_001128303.1 Q8N157-1Q8NER0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AHI1ENST00000265602.11 linkc.2962-16A>G intron_variant Intron 21 of 28 1 NM_001134831.2 ENSP00000265602.6 Q8N157-1

Frequencies

GnomAD3 genomes
AF:
0.00701
AC:
1066
AN:
152174
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00157
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00478
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.0184
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0106
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00676
AC:
1657
AN:
245052
AF XY:
0.00679
show subpopulations
Gnomad AFR exome
AF:
0.00137
Gnomad AMR exome
AF:
0.00356
Gnomad ASJ exome
AF:
0.000303
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0172
Gnomad NFE exome
AF:
0.00983
Gnomad OTH exome
AF:
0.00787
GnomAD4 exome
AF:
0.0100
AC:
14466
AN:
1441548
Hom.:
93
Cov.:
27
AF XY:
0.00985
AC XY:
7073
AN XY:
718166
show subpopulations
African (AFR)
AF:
0.00142
AC:
47
AN:
32988
American (AMR)
AF:
0.00411
AC:
182
AN:
44308
Ashkenazi Jewish (ASJ)
AF:
0.000193
AC:
5
AN:
25868
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39436
South Asian (SAS)
AF:
0.000457
AC:
39
AN:
85308
European-Finnish (FIN)
AF:
0.0143
AC:
753
AN:
52666
Middle Eastern (MID)
AF:
0.000721
AC:
4
AN:
5546
European-Non Finnish (NFE)
AF:
0.0119
AC:
13019
AN:
1095762
Other (OTH)
AF:
0.00699
AC:
417
AN:
59666
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
579
1158
1738
2317
2896
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
492
984
1476
1968
2460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00700
AC:
1066
AN:
152292
Hom.:
5
Cov.:
32
AF XY:
0.00720
AC XY:
536
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.00156
AC:
65
AN:
41572
American (AMR)
AF:
0.00477
AC:
73
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4824
European-Finnish (FIN)
AF:
0.0184
AC:
195
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0106
AC:
718
AN:
68002
Other (OTH)
AF:
0.00473
AC:
10
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
57
113
170
226
283
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00336
Hom.:
0
Bravo
AF:
0.00595
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 02, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinal disorders Benign:1
Oct 23, 2024
Genetics Laboratory, Great Ormond Street Hospital NHS Foundation Trust, North Thames Genomic Laboratory Hub
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS1_strong, BS2_strong -

Joubert syndrome Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AHI1: BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
5.0
DANN
Benign
0.83
PhyloP100
0.43
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41287056; hg19: chr6-135726131; API